Clinical Trial Update: ACD440 Gel in Peripheral Neuropathic Pain [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for ACD440 Gel in peripheral neuropathic pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Neuropathic Pain

Drugs mentioned

• ACD440 Gel (ACD440 Gel)

Snippet

Sponsor: AlzeCure Pharma | Conditions: Peripheral Neuropathic Pain | Phase 2 | Status: COMPLETED